Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Beijing Tiantan Biological Products Co., Ltd.
  6. Financials
    600161   CNE000000WF9

BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.

(600161)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 18 51229 20852 31041 648--
Entreprise Value (EV)1 18 51229 20852 31041 64841 64841 648
P/E ratio 36,6x48,2x81,8x55,0x45,0x37,3x
Yield 0,24%0,21%0,24%0,38%0,47%0,58%
Capitalization / Revenue 6,32x8,90x15,2x10,6x9,08x7,71x
EV / Revenue 6,32x8,90x15,2x10,6x9,08x7,71x
EV / EBITDA -24,7x42,0x41,0x34,1x27,9x
Price to Book 5,49x7,42x11,6x6,49x5,78x5,13x
Nbr of stocks (in thousands) 1 254 4401 254 4401 254 4401 373 175--
Reference price (CNY) 14,823,341,730,330,330,3
Announcement Date 04/01/201904/01/202004/26/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 2 9313 2823 4463 9444 5885 401
EBITDA1 -1 1821 2471 0171 2211 493
Operating profit (EBIT)1 8681 0471 1051 2771 5431 869
Operating Margin 29,6%31,9%32,1%32,4%33,6%34,6%
Pre-Tax Profit (EBT)1 8681 0431 1051 2871 5621 890
Net income1 5096116397609231 117
Net margin 17,4%18,6%18,5%19,3%20,1%20,7%
EPS2 0,400,480,510,550,670,81
Dividend per Share2 0,030,050,100,120,140,18
Announcement Date 04/01/201904/01/202004/26/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2019 Q2 2019 Q3
Net sales1 855959
EBITDA --
Operating profit (EBIT) --
Operating Margin --
Pre-Tax Profit (EBT) --
Net income --
Net margin --
EPS --
Dividend per Share --
Announcement Date 08/22/201910/24/2019
1 CNY in Million
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 38413393,85499121 184
ROE (Net Profit / Equities) 15,5%16,7%15,1%12,3%13,0%13,9%
Shareholders' equity1 3 2853 6554 2326 1857 0828 045
ROA (Net Profit / Asset) -10,7%9,22%9,63%10,4%11,0%
Assets1 -5 6916 9287 8878 89910 120
Book Value Per Share2 2,693,143,604,675,245,92
Cash Flow per Share2 0,540,510,560,720,901,08
Capex1 294509608470622753
Capex / Sales 10,0%15,5%17,7%11,9%13,6%13,9%
Announcement Date 04/01/201904/01/202004/26/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 41 648 386 072
Capitalization (USD) 6 520 397 356
Net sales (CNY) 3 445 594 870
Net sales (USD) 539 428 550
Number of employees 3 592
Sales / Employee (CNY) 959 241
Sales / Employee (USD) 150 175
Free-Float 41,1%
Free-Float capitalization (CNY) 17 119 175 123
Free-Float capitalization (USD) 2 680 147 654
Avg. Exchange 20 sessions (CNY) 332 181 470
Avg. Exchange 20 sessions (USD) 52 005 002
Average Daily Capital Traded 0,80%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA